SARS-CoV-2-specific neuropathology: fact or fiction?

Area of Science:

• Neuroscience
• Immunology
• Infectious Diseases

Background:

• COVID-19 is associated with neurological symptoms and central nervous system (CNS) immune alterations.
• Recent findings suggest heightened innate immune activation in CNS border regions, with compartmentalized cytokine responses and dysregulated cerebrospinal fluid (CSF) immune profiles.

Purpose of the Study:

• To review key findings regarding CNS immunopathology in COVID-19.
• To address the debate on whether observed CNS changes result from systemic inflammation or direct CNS viral infection.
• To identify future research directions.

Main Methods:

• Literature review and synthesis of existing research findings.
• Analysis of studies investigating CNS immune responses in COVID-19 patients.
• Discussion of evidence supporting bystander effects versus CNS-specific infection.

Main Results:

• Evidence points to increased innate immune activation and altered cytokine profiles within the CNS.
• A dysregulated and autoreactive CSF immune profile has been observed in some COVID-19 cases.
• The precise cause of these CNS immune changes remains under investigation.

Conclusions:

• The role of CNS immunopathology in COVID-19 is complex and debated.
• Distinguishing between systemic inflammation effects and CNS-specific viral impact is crucial.
• Further research is needed to elucidate the mechanisms driving neurological complications in COVID-19.